Arkolith/Insider Trading/SGTX/Form 4

Vivaldi Coelho Rogerio

PRESIDENT AND CEO, DirectorSigilon Therapeutics, Inc. (SGTX) · full profile →Form 4 · filed Jul 24, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2023Option exercise(M)6K$19.24$106K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2023Option exercise(M)6K—$012K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-011446) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML